Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway.
暂无分享,去创建一个
Lisa L. Smith | J. Byrd | A. Johnson | D. Jarjoura | K. Blum | L. Andritsos | X. Mo | N. Muthusamy | L. Pham | W. Blum | C. Rader | R. Lapalombella | A. Lehman | Qing Liu | S. May | C. A. Raymond | R. Ford | A. Ramanunni | Rebekah Browning | Ching S. Chen